Phase 1, Dose-Escalation, Pharmacodynamic Study of IV CNF1010 in ZAP-70 Positive CLL

NCT00319930 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped Discontinuation of program

Conditions

Interventions

Sponsor

Biogen